A biomarker is a physiological observable marker that acts as a stand-in and, in the best-
case scenario, forecasts a clinically significant outcome. Diagnostic biomarkers are more …

Surface plasmon resonance approach is a highly useful option to offer optical and label-free
detection of target bioanalytes with numerous advantages (eg, low-cost fabrication …

Cancer is the second leading cause of death worldwide after cardiovascular disease. The
major cause of high mortality is delayed detection. Therefore, detection at an early stage …

In this study, we report the development of a nanoparticle-enhanced biosensor by
integrating both the nanoparticles and immunoassay sensing technologies into a phase …

Cancer is the second most extended disease with an improved death rate over the past
several time. Due to the restrictions of cancer analysis methods, the patient's real survival …

Biomarker-based cancer analysis has great potential to lead to a better understanding of
disease at the molecular level and to improve early diagnosis and monitoring. Unlike …

The design and application of sensors for monitoring biomolecules in clinical samples is a
common goal of the sensing research community. Surface plasmon resonance (SPR) and …

Surface plasmon resonance (SPR) imaging sensors realize label-free, real-time, highly
sensitive, quantitative, high-throughput biological interaction monitoring and the binding …

Surface plasmon resonance (SPR) is a label-free detection method which has emerged
during the last two decades as a suitable and reliable platform in clinical analysis for …

Surface plasmon resonance (SPR) biosensor is a powerful tool for studying the kinetics of
biomolecular interactions because they offer unique real-time and label-free measurement …